These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 15990777)
1. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777 [TBL] [Abstract][Full Text] [Related]
2. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073 [TBL] [Abstract][Full Text] [Related]
3. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Wilson DR; Irani AM; Walker SM; Jacobson MR; Mackay IS; Schwartz LB; Durham SR Clin Exp Allergy; 2001 Nov; 31(11):1705-13. PubMed ID: 11696046 [TBL] [Abstract][Full Text] [Related]
4. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Ying S; Durham SR; Jacobson MR; Rak S; Masuyama K; Lowhagen O; Kay AB; Hamid QA Immunology; 1994 Jun; 82(2):200-6. PubMed ID: 7927489 [TBL] [Abstract][Full Text] [Related]
5. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis. Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853 [TBL] [Abstract][Full Text] [Related]
6. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488 [TBL] [Abstract][Full Text] [Related]
7. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Pullerits T; Lindén A; Malmhäll C; Lötvall J Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252 [TBL] [Abstract][Full Text] [Related]
8. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
9. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. Varney VA; Hamid QA; Gaga M; Ying S; Jacobson M; Frew AJ; Kay AB; Durham SR J Clin Invest; 1993 Aug; 92(2):644-51. PubMed ID: 8349803 [TBL] [Abstract][Full Text] [Related]
10. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge. Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650 [TBL] [Abstract][Full Text] [Related]
12. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033 [TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Savolainen J; Jacobsen L; Valovirta E Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566 [TBL] [Abstract][Full Text] [Related]
14. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Rak S; Heinrich C; Scheynius A Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810 [TBL] [Abstract][Full Text] [Related]
15. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid. Sergejeva S; Malmhäll C; Lötvall J; Pullerits T Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263 [TBL] [Abstract][Full Text] [Related]
16. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796 [TBL] [Abstract][Full Text] [Related]
17. [Humoral mucosal immunity in allergic rhinitis]. Kramer MF; Jordan TR; Pfrogner E; Rasp G Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632 [TBL] [Abstract][Full Text] [Related]
18. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens. Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414 [TBL] [Abstract][Full Text] [Related]
19. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338 [TBL] [Abstract][Full Text] [Related]
20. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-beta, eotaxin, and stem cell factor and their receptors in allergic rhinitis. Salib RJ; Kumar S; Wilson SJ; Howarth PH J Allergy Clin Immunol; 2004 Oct; 114(4):799-806. PubMed ID: 15480318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]